We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report on Provenge for CMS Confirms Vaccine’s Effectiveness
Report on Provenge for CMS Confirms Vaccine’s Effectiveness
November 12, 2010
As the Centers for Medicare & Medicaid Services (CMS) prepares to consider the evidence for extending coverage to Dendreon’s prostate cancer drug Provenge, an independent review has failed to raise red flags about its effectiveness.